These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30680153)

  • 41. Outcomes of intrahospital antimicrobial stewardship programs related to prevention of Clostridium difficile infection outbreaks.
    Mijović B; Dubravac Tanasković M; Račić M; Bojanić J; Stanić S; Banković Lazarević D
    Med Glas (Zenica); 2018 Aug; 15(2):122-131. PubMed ID: 30047540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
    Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
    Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
    Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain.
    Salavert M; Cobo J; Pascual Á; Aragón B; Maratia S; Jiang Y; Aceituno S; Grau S
    Adv Ther; 2018 Nov; 35(11):1920-1934. PubMed ID: 30328061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic Stewardship Programs in U.S. Acute Care Hospitals: Findings From the 2014 National Healthcare Safety Network Annual Hospital Survey.
    Pollack LA; van Santen KL; Weiner LM; Dudeck MA; Edwards JR; Srinivasan A
    Clin Infect Dis; 2016 Aug; 63(4):443-9. PubMed ID: 27199462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between statewide adoption of the CDC's Core Elements of Hospital Antimicrobial Stewardship Programs and rates of methicillin-resistant
    Garcia Reeves AB; Lewis JW; Trogdon JG; Stearns SC; Weber DJ; Weinberger M
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):430-437. PubMed ID: 31858919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An interprofessional approach to reducing hospital-onset Clostridioides difficile infections.
    Walter C; Soni T; Gavin MA; Kubes J; Paciullo K
    Am J Infect Control; 2022 Dec; 50(12):1346-1351. PubMed ID: 35569613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leveraging Quality Improvement Science to Reduce C. difficile Infections in a Community Hospital.
    Lambl BB; Altamimi S; Kaufman NE; Rein MS; Freeley M; Duram M; Krauss W; Kurowski J; O'Neill WE; Seeley P; Gagnon MJ; Phillips DE; Rubin MS
    Jt Comm J Qual Patient Saf; 2019 Apr; 45(4):285-294. PubMed ID: 30527394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
    Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic healthcare costs of Clostridium difficile infection: a systematic review.
    Ghantoji SS; Sail K; Lairson DR; DuPont HL; Garey KW
    J Hosp Infect; 2010 Apr; 74(4):309-18. PubMed ID: 20153547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland.
    Robertson C; Pan J; Kavanagh K; Ford I; McCowan C; Bennie M; Marwick C; Leanord A
    J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management.
    Pai S; Aliyu SH; Enoch DA; Karas JA
    PLoS One; 2012; 7(12):e51728. PubMed ID: 23300561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
    Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
    J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reducing Clostridium difficile incidence, colectomies, and mortality in the hospital setting: a successful multidisciplinary approach.
    Mermel LA; Jefferson J; Blanchard K; Parenteau S; Mathis B; Chapin K; Machan JT
    Jt Comm J Qual Patient Saf; 2013 Jul; 39(7):298-305. PubMed ID: 23888639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of Infection Due to Clostridium difficile.
    Cooper CC; Jump RL; Chopra T
    Infect Dis Clin North Am; 2016 Dec; 30(4):999-1012. PubMed ID: 27660089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.
    Zhang S; Palazuelos-Munoz S; Balsells EM; Nair H; Chit A; Kyaw MH
    BMC Infect Dis; 2016 Aug; 16(1):447. PubMed ID: 27562241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units.
    Ruiz-Ramos J; Frasquet J; Romá E; Poveda-Andres JL; Salavert-Leti M; Castellanos A; Ramirez P
    J Med Econ; 2017 Jun; 20(6):652-659. PubMed ID: 28345481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
    Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.